Neuroprotection: Challenges and Opportunities
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The ability of pharmacological agents to limit secondary biochemical damage and cell death has been well established in numerous animal models of stroke, head injury, and spinal cord injury, yet the results of such neuroprotective treatment strategies in human injury have been disappointing. A number of conceptual and methodological issues have undoubtedly contributed to the difficulties in translating the experimental results to the clinic. Most recently, different experimental approaches and altered clinical trial methodologies have provided renewed, albeit cautious, optimism regarding future clinical trials of neuroprotective agents. Herein, we reviewed both the critical problems and potential solutions, emphasizing recent experimental and clinical work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Cited by
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
Cheng, G., Kong, R., Zhang, L., & Zhang, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02025.x · Cited by 343
New perspectives on central and peripheral immune responses to acute traumatic brain injury
Das, M., Mohapatra, S., & Mohapatra, S. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-236 · Cited by 281
Cell Death Mechanisms and Modulation in Traumatic Brain Injury
Stoica, B. A., & Faden, A. I. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2009.10.023 · Cited by 276
Self-citationNeuroprotective Strategies for Traumatic Brain Injury: Improving Clinical Translation
Kabadi, S., & Faden, A. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15011216 · Cited by 170
“One difference may be the post hoc deletion of animal subjects because of an outlier in outcomes or animal subjects not meeting the injury criteria; in contrast clinical trials use intent-to-treat paradigms, where data are not excluded because of errors in drug preparation or administration, and/or variability in the…”
ResultSelf-citation
Metadata
- Authors
- Faden, A. I., & Stoica, B.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2007-06-01
- Volume
- 64
- Issue
- 6
- Pages
- 794
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2058411142
- Cited by
- 120
- References
- 2
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.